20102016
If you made any changes in Pure these will be visible here soon.

Research Output 2010 2016

2016

Biomarkers in non-small cell lung cancer: focus on angiogenesis

van den Boogaart, V., 2016

Research output: ThesisDoctoral ThesisInternal

Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib

van den Boogaart, V., de Lussanet, Q. G., Houben, R., de Ruysscher, D., Groen, H. J. M., Marcus, J. T., Smit, E. F., Dingemans, A-M. C. & Backes, W. H., Mar 2016, In : Lung Cancer. 93, p. 20-27

Research output: Contribution to journalArticleAcademicpeer-review

2011

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

Dingemans, A. -M. C., de Langen, A. J., van den Boogaart, V., Marcus, J. T., Backes, W. H., Scholtens, H. T. G. M., van Tinteren, H., Hoekstra, O. S., Pruim, J., Brans, B., Thunnissen, F. B., Smit, E. F. & Groen, H. J. M., Mar 2011, In : Annals of Oncology. 22, 3, p. 559-566

Research output: Contribution to journalArticleAcademicpeer-review

Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI

de Langen, A. J., van den Boogaart, V., Lubberink, M., Backes, W. H., Marcus, J. T., van Tinteren, H., Pruim, J., Brans, B., Leffers, P., Dingemans, A-M. C., Smit, E. F., Groen, H. J. M. & Hoekstra, O. S., 1 Jan 2011, In : Journal of Nuclear Medicine. 52, 1, p. 48-55

Research output: Contribution to journalArticleAcademicpeer-review

2010

Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer

Dingemans, A-M. C., van den Boogaart, V., Vosse, B. A., van Suylen, R-J., Griffioen, A. W. & Thijssen, V. L., 17 Jun 2010, In : Molecular Cancer. 9, p. 9

Research output: Contribution to journalArticleAcademicpeer-review